SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Try telling your doctor you want a deal on the Artificial Heart
SYK
|
|
|
+31.27%
in
220 days
The money is rolling in it is just a matter of Stryker putting out a few new products they have in the cartridge and bam this baby is going to take off with advertising and marketing cash to make your money sing.
|
Bullish on SYK ...
SYK
|
|
|
-26.40%
in
497 days
Analysts' Recommendation: Buy 30 Days Ago: Buy Analysts' Target: $76 Analysts' Targets Deutsche Bank Securities $73 Neutral Thursday, July 10, 2008 Leerink Swann & Company $76 Mkt Perform Monday, June 23, 2008 Robert W. Baird & Co. $80 Hold Thursday, January 24, 2008 Stryker Corporation, together with its subsidiaries, operates as a medical technology company worldwide. It operates in two segments, Orthopaedic Implants and MedSurg Equipment. The Orthopedic Implants segment provides orthopedic reconstructive, spinal, and craniomaxill...
|
Tried and True in Troubled Times!
SYK
|
|
|
-22.06%
in
503 days
Stryker has "always" had a strong financial position with lots of cash and great management. In trying markets investors are seeking rock-solid companies that can weather the rough seas that we are experiencing. As the Baby-Boomers age (along with their hips, knees, etc.) the demand for orthopaedic products has to keep pace. If you look at a chart of Stryker's performance over the past twenty-so years you see steady growth and, with four splits thrown in, an overall PPS increase of over 8,000%! Steady dividends- steady double digit growth! Innovative, flexible and worthy of a strong buy! ...
|
"Looking Back One Year" A review of stock picks from the week of March 13, 2006
SYK
|
|
|
-26.89%
in
810 days
 Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisers prior to making any investment decisions based on information on this website. I hope you all are having a good Labor Day Holiday (for those of you outside the United States, I also wish you a wonderful weekend!). <> Always thinking about informing my readers nd learning more myself, I would like to share this commentary ab...
|
From the Blogosphere
Zimmer to Sell Notes – Analyst Blog
|
|
|
Zimmer Holdings, Inc. (ZMH) recently decided to raise $1 billion by selling its senior unsecured notes in an underwritten public offering in two separate transactions. The transactions involve selling $500.0 million of 4.625% notes due 2019 and $500.0 million of 5.75% notes due 2039. The public offering is expected to close on Nov 17, 2009.
Zimmer has already filed an automatic shelf registration statement on Form S-3 with the Securities and Exchange Commission for the public offer. Citigroup Global Markets Inc., a division of Citigroup, Inc. (C); Banc of America Securities LLC, a divisio...
|
Zacks Analyst Blog Highlights: Stryker Corp., Synergetics USA, Inc., Zimmer Holdings, Conmed Corporation and Smith & Nephew – Press Releases
|
|
|
For Immediate Release Chicago, IL – November 13, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Stryker Corp. (SYK), Synergetics USA, Inc. (SURG), Zimmer Holdings (ZMH), Conmed Corporation (CNMD) and Smith & Nephew (SNN). Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513 <><>Here are highlights from Thursday’s Analyst <><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< />< />< />< /><><><><>< /><><>< /><>< /><>< />< />...
|
Stryker Strikes Acquisition Deals – Analyst Blog
|
|
|
Stryker Corp. (SYK) is on a takeover spree having made three acquisitions recently. The company acquired OtisMed Corp., Mutoh Co. Ltd. and certain of its affiliates, and Synergetics USA, Inc. (SURG). Financial terms of these transactions include $67 million in upfront payment as well as potential future milestone and royalty payments of up to $36 million. These acquisitions are expected to be completed by the end of 2009. <>OtisMed Corp. is a privately held software technology firm that focuses on customizable instrumentation complementing Stryker’s Triathlon Knee System, as well as other St< />< />< />< />< />< /><><><><><><><><><><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><><>< /><>< /><>< />< />...
|
Wright Receives FDA Approval – Analyst Blog
|
|
|
Wright Medical Group, Inc. (WMGI) recently received the Food and Drug administration (FDA) approval to market its CONSERVE Plus Total Hip Resurfacing System in the U.S. The new system, which has received FDA approval, provides surgeons with a bone-conserving alternative to traditional total hip replacement.
With the FDA approval, Wright Medical can now market CONSERVE Plus in the original femoral and acetabular component configuration in the U.S. as specified in its PreMarket Approval (PMA) application with the FDA. The company also intends to develop additional enhancements to the system...
|
Cramer on BloggingStocks: Pelosi can't kill the health care sector
SYK
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|
About Stryker Corp.
- Answers.com
